Safety and efficacy of arimoclomol for inclusion body myositis: a multicentre, randomised, double-blind, placebo-controlled trialPedro Machado, Sarah Heintzman, Michael McDermott et al.|The Lancet Neurology|2023Cited by 35
The immune system in sporadic inclusion body myositis patients is not compromised by blood-flow restricted exercise trainingKasper Yde Jensen, Ulrik Frandsen, Eleanor Boyle et al.|Arthritis Research & Therapy|2019Cited by 18
Lack of muscle stem cell proliferation and myocellular hypertrophy in sIBM patients following blood-flow restricted resistance trainingKasper Yde Jensen, Louise Pyndt Diederichsen, Jakob Lindberg Nielsen et al.|Neuromuscular Disorders|2022Cited by 5